Mesenchymal stromal cells for acute graft-versus-host disease: response at 1 week predicts probability of survival

被引:30
|
作者
Galleu, Antonio [1 ,2 ]
Milojkovic, Dragana [3 ]
Deplano, Simona [3 ]
Szydlo, Richard [4 ]
Loaiza, Sandra [3 ]
Wynn, Robert [5 ]
Marks, David I. [6 ]
Richardson, Deborah [7 ]
Orchard, Kim [7 ]
Kanfer, Edward [3 ]
Tholouli, Eleni [5 ]
Saif, Muhammad [5 ]
Sivaprakasam, Ponni [6 ]
Lawson, Sarah [8 ]
Bloor, Adrian [9 ]
Pagliuca, Antonio [10 ]
Potter, Victoria [10 ]
Mehra, Varun [10 ]
Snowden, John A. [11 ]
Vora, Ajay [12 ]
Kishore, Bhuvan [13 ]
Hunter, Hannah [14 ]
Apperley, Jane F. [3 ,4 ]
Dazzi, Francesco [1 ,2 ,3 ,4 ]
机构
[1] Kings Coll London, London, England
[2] Kings Hlth Partners Canc Res UK Ctr, London, England
[3] Imperial Coll Healthcare NHS Trust, London, England
[4] Imperial Coll London, London, England
[5] Cent Manchester Univ Hosp, Manchester, Lancs, England
[6] Univ Hosp Bristol, Bristol, Avon, England
[7] Southampton Univ Hosp, Southampton, Hants, England
[8] Birmingham Womens & Childrens Hosp, Birmingham, W Midlands, England
[9] Christie NHS Fdn Trust, Manchester, Lancs, England
[10] Kings Coll Hosp NHS Trust, London, England
[11] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England
[12] Sheffield Childrens Hosp, Sheffield, S Yorkshire, England
[13] NHS Fdn Trust, Heart England, Birmingham, W Midlands, England
[14] Plymouth Hosp NHS Trust, Plymouth, Devon, England
关键词
cellular therapies; GvHD; mesenchymal cells; clinical research; stromal cells; STEM-CELLS; STEROID-RESISTANT; ACUTE GVHD; GRADE III; THERAPY;
D O I
10.1111/bjh.15749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mesenchymal stromal cells (MSCs) have been successfully used for the treatment of steroid-resistant graft-versus-host-disease (GvHD). However, the lack of early predictors of clinical responses impacts on the time at which to add further treatment and consequently the design of informative clinical trials. Here, we present the UK experience of one of the largest cohorts of GvHD patients undergoing MSC infusions so far reported. We show that clinical responses assessed as early as 1 week after MSC infusion predict patients' overall survival. In our cohort, cell dose, patients' age and type of organ involvement are crucial factors associated with clinical responses.
引用
收藏
页码:89 / 92
页数:4
相关论文
共 50 条
  • [1] Harnessing and honing mesenchymal stem/stromal cells for the amelioration of graft-versus-host disease
    Jaing, Tang-Her
    Chang, Tsung-Yen
    Chiu, Chia-Chi
    WORLD JOURNAL OF STEM CELLS, 2023, 15 (04): : 221 - 234
  • [2] Clinical Use of Mesenchymal Stromal Cells in the Treatment of Acute Graft-versus-Host Disease
    Elgaz, Sumeyye
    Kuci, Zyrafete
    Kuci, Selim
    Boenig, Halvard
    Bader, Peter
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2019, 46 (01) : 27 - 34
  • [3] Mesenchymal Stromal Cells: What Is the Mechanism in Acute Graft-Versus-Host Disease?
    Dunavin, Neil
    Dias, Ajoy
    Li, Meizhang
    McGuirk, Joseph
    BIOMEDICINES, 2017, 5 (03)
  • [4] Mesenchymal Stromal Cells for Graft-versus-Host Disease: A Trilogy
    Galipeau, Jacques
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (05) : E89 - E91
  • [5] Mesenchymal stromal cells: potential roles in graft-versus-host disease prophylaxis and treatment
    Maziarz, Richard T.
    TRANSFUSION, 2016, 56 (04) : 9S - 14S
  • [6] Mesenchymal Stromal Cells for Graft-Versus-Host Disease
    Tolar, Jakub
    Villeneuve, Pierre
    Keating, Armand
    HUMAN GENE THERAPY, 2011, 22 (03) : 257 - 262
  • [7] Mesenchymal Stromal Cells for the Treatment of Graft Versus Host Disease
    Kelly, Kilian
    Rasko, John E. J.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [8] Multipotent mesenchymal stromal cells application for acute graft versus host disease treatment
    Kuzmina, L. A.
    Petinati, N. A.
    Vasilieva, V. A.
    Dovydenko, M., V
    Drokov, M. Yu
    Davydova, Yu O.
    Kapranov, N. M.
    Sats, N., V
    Chabaeva, Yu A.
    Kulikov, S. M.
    Gaponova, T., V
    Drize, N., I
    Parovichnikova, E. N.
    Savchenko, V. G.
    TERAPEVTICHESKII ARKHIV, 2020, 92 (07) : 23 - 30
  • [9] Gastrointestinal Acute Graft-versus-Host Disease in Children: Histology for Diagnosis, Mesenchymal Stromal Cells for Treatment, and Biomarkers for Prediction of Response
    Calkoen, Friso G. J.
    Jol-van der Zijde, Cornelia M.
    Mearin, M. Luisa
    Schweizer, Joachim J.
    Jansen-Hoogendijk, Anja M.
    Roelofs, Helene
    van Halteren, Astrid G. S.
    Egeler, R. Maarten
    van Tol, Maarten J. D.
    Ball, Lynne M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (11) : 1590 - 1599
  • [10] Mesenchymal Stromal Cells: A New Tool against Graft-versus-Host Disease?
    Baron, Frederic
    Storb, Rainer
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (06) : 822 - 840